Title
Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation
Date Issued
01 June 2010
Access level
open access
Resource Type
journal article
Author(s)
Mora-Castilla S.
Hmadcha A.
Cahuana G.M.
Martín F.
Soria B.
Bedoya F.J.
Universidad Pablo de Olavide
Abstract
Exposure of mouse embryonic stem (mES) cells to high concentrations of chemical nitric oxide (NO) donors promotes differentiation, but the mechanisms involved in this process at the gene expression level are poorly defined. In this study we report that culture of mES cells in the presence of 0.25-1.0 mM diethylenetriamine nitric oxide adduct (DETA-NO) leads to downregulation of Nanog and Oct4, the two master genes involved in the control of the pluripotent state. This action of NO was also apparent in the human ES cell line, HS 181. The suppressive action of NO on Nanog gene depends on the activation of p53 repressor protein by covalent modifications, such as pSer15, pSer315, pSer392 and acetyl Lys 379. NO-induced repression of Nanog is also associated with binding of trimethylated histone H3 and pSer315 p53 to its promoter region. In addition, exposure to 0.5 mM DETA-NO induces early differentiation events of cells with acquisition of epithelial morphology and expression of markers of definitive endoderm, such as FoxA2, Gata4, Hfn1-Β and Sox 17. This phenotype was increased when cells were treated with valproic acid (VPA) for 10 days. © 2010 Macmillan Publishers Limited All rights reserved.
Start page
1025
End page
1033
Volume
17
Issue
6
Language
English
OCDE Knowledge area
Bioquímica, Biología molecular
Subjects
Scopus EID
2-s2.0-77952238024
PubMed ID
Source
Cell Death and Differentiation
ISSN of the container
14765403
Sponsor(s)
Acknowledgements. We thank M Bautista and AB Hitos for technical assistance and A Rojas for assistance in ChIP technique. S Mora-Castilla is fellow from Ministerio de Educación y Ciencia. This study was supported by grants from Dirección General de Investigación Científica y Técnica (SAF2007/60105), Instituto de Salud Carlos III (TERCEL RD06/0010/0025) and Junta de Andalucía (CTS576) to FJ Bedoya; from Fondo de Investigaciones Sanitarias (FIS-052106) and Dirección General de Investigación Científica y Técnica (CYT-836, SAF2005-08014) to B Soria; from Dirección General de Investigación Científica y Técnica (SAF2003-03307; SAF2006-06673), Junta de Andalucía (exp. 0009/06) and Instituto de Salud Carlos III (RCMN C03/08, RETIC RD06/0015/0013 and CIBERDEM) to F Martín; and from Consejería de Salud-Junta de Andalucía (PI-0095/2007) and Instituto de Salud Carlos III (CIBERDEM) to JR Tejedo.
Sources of information:
Directorio de Producción Científica
Scopus